Amgen Inc. (NASDAQ:AMGN) and AstraZeneca PLC (NYSE:AZN) received a positive boost after their combination of Amgen’s ...

Getting there, however, will require enormous amounts of computing power, Haas said.

Remission rates observed in a Phase 2 trial fell short of Wall Street's expectations, though some analysts believe the ...

Shares of ImmunityBio, Inc. (IBRX) are heading toward their steepest weekly decline since July as investors weigh a newly published patent application outlining broader potential uses for Anktiva ...

Tyra Biosciences Inc. ( TYRA) shares are currently trading at $20.77, down $5.96, or 22.27 percent on Wednesday, despite the company reporting encouraging initial results from its Phase 2 SURF302 ...

Cancer center leaders discuss how joining ConcertAI's CancerLinQ network cut QOPI data abstraction time, while enabling data insights and benchmarking.

“1 in 20 Iowans have had a diagnosis of cancer in their lifetime, and if the trends continue, we’re headed towards one in 10.” Dr. Mary Charlton, Director of the Iowa Cancer Registry SIOUX CITY (KTIV) ...

Credit: Getty Images. Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. Breast cancer is the second most common cancer ...

Source: Getty Images Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. These numbers are higher than estimates from 2023, ...